China Sxt Pharmaceuticals, Inc. (SXTC) — 20-F Filings
All 20-F filings from China Sxt Pharmaceuticals, Inc.. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
China SXT Pharma Files 20-F, Confirms NASDAQ Listing & Compliance
— Jul 31, 2025 Risk: low
China SXT Pharmaceuticals, Inc. (SXTC) filed its 20-F for the fiscal year ended March 31, 2025, indicating its status as an annual report pursuant to Section 13 -
China SXT Pharmaceuticals Files 2024 Annual Report
— Aug 13, 2024 Risk: medium
China SXT Pharmaceuticals, Inc. filed its annual report on Form 20-F for the fiscal year ended March 31, 2024. The company, incorporated in the British Virgin I
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX